Serologic response in patients with paroxysmal nocturnal hemoglobinuria (PNH) after vaccination against meningococci for the chronic treatment with the terminal complement inhibitor eculizumab: A retrospective analysis

被引：0
|
作者：
Alashkar, F. [1 ]
Herich-Terhuerne, D. [1 ]
Duehrsen, U. [1 ]
Roeth, A. [1 ]
机构：
[1] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Klin Hamatol, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V755
引用
收藏
页码：245 / 246
页数：2
相关论文
共 50 条
  • [41] Fate of GPI-deficient clones in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): a retrospective analysis
    Roeth, A.
    Schmuecker, U.
    Tokareva, O.
    Preising, N.
    Hock, C.
    Duehrsen, U.
    [J]. ONKOLOGIE, 2012, 35 : 24 - 24
  • [42] Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Rondelli, Tommaso
    Risitano, Antonio M.
    de Latour, Regis Peffault
    Sica, Michela
    Peruzzi, Benedetta
    Ricci, Patrizia
    Barcellini, Wilma
    Iori, Anna Paola
    Boschetti, Carla
    Valle, Veronica
    Fremeaux-Bacchi, Veronique
    De Angioletti, Maria
    Socie, Gerard
    Luzzatto, Lucio
    Notaro, Rosario
    [J]. HAEMATOLOGICA, 2014, 99 (02) : 262 - 266
  • [43] Genetic Polymorphism of the Complement Receptor-1 (CR1) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Rondelli, Tommaso
    Risitano, Antonio M.
    de Latour, Regis Peffault
    Peruzzi, Benedetta
    Patrizia, Ricci
    Barcellini, Wilma
    Iori, Anna Paola
    Boschetti, Carla
    Valle, Veronica
    Fremeaux-Bacchi, Veronique
    De Angioletti, Maria
    Socie, Gerard
    Luzzatto, Lucio
    Notaro, Rosario
    [J]. BLOOD, 2012, 120 (21)
  • [44] Efficacy and Safety of Single Agent Proximal Complement Inhibitors in Paroxysmal Nocturnal Hemoglobinuria ( PNH) Patients with Residual Anemia Despite of Adequate Terminal Complement Inhibitor Use
    Veeramreddy, Padmaja
    Sanikommu, Srinivasa Reddy
    [J]. BLOOD, 2023, 142
  • [45] The phase III randomized, multicenter commodore 1 trial: comparison of crovalimab vs eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Roeth, A.
    Scheinberg, P.
    Villa Cle, D.
    Edwards, J.
    Giai, V.
    Hus, M.
    Kim, J. S.
    Barrenetxea Lekue, C.
    Nagy, Z.
    Nur, E.
    Panse, J.
    Ueda, Y.
    Yenerel, M. N.
    Appius, A.
    Balachandran, N.
    Chebon, S.
    Gentile, B.
    Buatois, S.
    Kulasekararaj, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 200 - 201
  • [46] Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena
    Alexander Röth
    Christina Hock
    Anna Konik
    Sandra Christoph
    Ulrich Dührsen
    [J]. International Journal of Hematology, 2011, 93 : 704 - 714
  • [47] Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena
    Roeth, Alexander
    Hock, Christina
    Konik, Anna
    Christoph, Sandra
    Duehrsen, Ulrich
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 704 - 714
  • [48] 51-Cr labelled red blood cells (RBC) kinetics in paroxysmal nocturnal hemoglobinuria (PNH) patients with suboptimal response to the complement inhibitor eculizumab: physiopathologic insights and therapeutic suggestions
    Tabacco, P.
    Risitano, A. M.
    Seneca, E.
    Marando, L.
    Barbano, F.
    Valle, G.
    Ritrovato, G.
    Carella, A. M.
    Rotoli, B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S459 - S459
  • [49] First approved C3 Complement Inhibitor offers new Opportunities for Patients with paroxysmal nocturnal Hemoglobinuria (PNH)
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (05)
  • [50] Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report
    Mandala, E.
    Lafaras, C.
    Goulis, I
    Tsioni, K.
    Georgopoulou, V
    Ilonidis, G.
    [J]. HIPPOKRATIA, 2013, 17 (01) : 81 - 84
12345